Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
43 /100
MEDIUM RISK
Score updated Oct 13, 2026

CGTX — Cognition Therapeutics, Inc. Dilution Risk Tracker

Track CGTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CGTX — Get alerts when the score changes →

As of October 13, 2026, Cognition Therapeutics, Inc. (CGTX) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. Cognition Therapeutics, Inc. has a market capitalization of $81.49M, 95.09M shares outstanding, 75 institutional holders tracked. Stored dilution-related fields include 514.5K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄 Convertible Debt
60

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 29%
🔁 Convertible Conversion model 40%
• Significant convertible debt: 15% potential dilution
• Elevated convertible risk (60/100)
🔄 Reverse Split model est. 30%
• 50-day avg $1.11 approaching $1 threshold
🔔 Track CGTX — Get forecast alerts →

Market Data

Market Cap$81.49M
Shares Outstanding95.09M
Float81.85M
Cash$34.01M
Debt$638.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore43/100DilutionWatch score record
Shares Outstanding95.09MVerified float table or market cache
Public Float81.85MVerified float table or market cache
Market Cap$81.49MMarket data cache
Cash Runway16.1 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants514.5KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 4.7% shares (2026Q1 vs prior)
75 institutional holders · 24.65M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 6.00M shares
#2 BIOS Capital Management, LP 6.00M shares
#3 DAVENPORT & Co LLC 2.89M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest7.58M
Days to Cover16.6
% of Float9.3%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-07
xbrl XBRL CONVERTIBLE 2023-03-23
4 INSIDER TRANSACTION 2026-02-18
4 INSIDER TRANSACTION 2026-02-18
4 INSIDER TRANSACTION 2026-02-18
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual CGTX Dilution Snapshot

Cognition Therapeutics, Inc. (CGTX) has a DilutionScore of 43/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

CGTX's DilutionScore is currently 43/100 (Medium risk), with 4 score changes tracked over 89 days. The score improved from 39/100 (Medium risk).

Period Score Risk Level Duration
Oct 13, 202643/100MEDIUM1 day
Sep 28 – Oct 12, 202639/100MEDIUM15 days
Aug 24 – Sep 27, 202643/100MEDIUM35 days
Aug 22 – Aug 23, 202648/100MEDIUM2 days
Jul 16 – Aug 21, 202646/100MEDIUM36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

CGTX shares outstanding have increased 0.2% from 89.35M (Mar 2026) to 89.50M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 29, 202689.50M81.85M▼ 0.55%
Apr 27, 202689.35M82.31M▼ 0.27%
Apr 03, 202689.35M82.53M▲ 0.10%
Mar 27, 202689.35M82.45M▲ 1.22%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track CGTX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment CGTX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking CGTX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for CGTX
CGTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.